Bortezomib 2mg Injection

Bortezomib 2mg Injection Specification

Usage
Hospital

Storage
Dry Place

Grade
Pharma

Dosage
2 mg

Appearance
Liquid

Medicine Type
Anti Cancer

Bortezomib 2mg Injection Trade Information

Minimum Order Quantity
100 Boxes

Supply Ability
5000 Boxes Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Bortezomib 2mg Injection

Bortezomib 2mg Injection is a medication used in the treatment of multiple myeloma and certain types of lymphoma. It is administered by injection into a vein (intravenously) under the supervision of a healthcare professional. By blocking proteasome activity, bortezomib disrupts the normal functioning of cancer cells and induces cell death. This works by inhibiting the activity of proteasomes, which are protein complexes that play a critical role in the regulation of cell growth and survival. Bortezomib 2mg Injection is effective in the treatment of multiple myeloma and mantle cell lymphoma, both as a first-line treatment and in patients who have relapsed or are refractory to other therapies.

Specification

Manufactured By	Natco Pharma Ltd
Brand	Natco
Dose/Strength	2 mg
Packaging Type	Vial
Shelf life	24 month
Usage/Application	Clinical

Advanced Cancer Treatment Solution

Bortezomib 2mg Injection stands out as a reliable and potent anti-cancer drug used in clinical settings. Known for its role in treating certain types of cancer, such as multiple myeloma and mantle cell lymphoma, this injection is trusted by healthcare professionals. Sourced from leading exporters and wholesalers in India, it ensures quality and efficacy for patient care.

Safe Handling and Storage Guidelines

To retain its therapeutic effectiveness, Bortezomib 2mg Injection must be stored in a dry place, away from moisture and direct sunlight. Proper storage is crucial in hospital environments to maintain the medicine's integrity before administration. Healthcare personnel are trained to handle this formulation safely, prioritizing both efficacy and patient safety.

FAQ's of Bortezomib 2mg Injection:

Q: How should Bortezomib 2mg Injection be stored in a hospital setting?

A: Bortezomib 2mg Injection should be stored in a dry place, protected from moisture and direct sunlight. Proper storage helps maintain its stability and ensures the medication retains its efficacy until use.

Q: What is the recommended usage for Bortezomib 2mg Injection?

A: This anti-cancer injection is administered in hospital settings by medical professionals. It is given intravenously and dosage is precisely controlled to 2 mg per administration, following a prescribed treatment plan.

Q: When is Bortezomib 2mg Injection typically used during cancer therapy?

A: Bortezomib 2mg Injection is often prescribed as part of a chemotherapy regimen for conditions like multiple myeloma and mantle cell lymphoma. It is administered during treatment cycles planned by oncologists based on patient-specific protocols.

Q: Where is Bortezomib 2mg Injection available for procurement?

A: Hospitals can obtain Bortezomib 2mg Injection from Indian exporters and wholesalers specializing in pharmaceutical products. It is distributed for use in accredited medical facilities to ensure proper administration and quality control.

Q: What is the process for administering Bortezomib 2mg Injection?

A: A trained healthcare provider administers the injection intravenously in a controlled hospital environment. Dosage and treatment schedules are tailored individually under expert supervision to maximize therapeutic benefit and minimize side effects.

Q: What are the primary benefits of Bortezomib 2mg Injection for cancer patients?

A: As a pharma-grade anti-cancer medicine, Bortezomib 2mg targets malignant cells, inhibiting their growth and supporting better clinical outcomes. It offers a vital tool for oncologists in managing difficult-to-treat cancers.